Christian BOREL


ORCID – ResearcherID





Liste des publications :


Borel, C., Regnier-Gavier, O., Carinato, H., Guihard, S., Antoni, D., Demarchi, M., … Coliat, P. (2018). Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer. Oncotarget, 9(101), 37581–37588.
Jégu, J., Belot, A., Borel, C., Daubisse-Marliac, L., Trétarre, B., Ganry, O., … Velten, M. (2015). Effect of previous history of cancer on survival of patients with a second cancer of the head and neck. Oral Oncology, 51(5), 457–463.
Jégu, J., Binder-Foucard, F., Borel, C., & Velten, M. (2013). Trends over three decades of the risk of second primary cancer among patients with head and neck cancer. Oral Oncology, 49(1), 9–14.
Le Tourneau, C., Jung, G.-M., Borel, C., Bronner, G., Flesch, H., & Velten, M. (2008). Prognostic factors of survival in head and neck cancer patients treated with surgery and postoperative radiation therapy. Acta Oto-Laryngologica, 128(6), 706–712.
Le Tourneau, C., Velten, M., Jung, G.-M., Bronner, G., Flesch, H., & Borel, C. (2005). Prognostic indicators for survival in head and neck squamous cell carcinomas: analysis of a series of 621 cases. Head & Neck, 27(9), 801–808.
Petit, T., Wilt, M., Velten, M., Millon, R., Rodier, J.-F., Borel, C., … Ghnassia, J.-P. (2004). Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy. European Journal of Cancer (Oxford, England: 1990), 40(2), 205–211.
Cutuli, B., Borel, C., Dhermain, F., Magrini, S. M., Wasserman, T. H., Bogart, J. A., … Velten, M. (2001). Breast cancer occurred after treatment for Hodgkin’s disease: analysis of 133 cases. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, 59(3), 247–255.
Petit, T., Georges, C., Jung, G. M., Borel, C., Bronner, G., Flesch, H., … Schraub, S. (2001). Systematic esophageal endoscopy screening in patients previously treated for head and neck squamous-cell carcinoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology, 12(5), 643–646.
Cutuli, B., Dhermain, F., Borel, C., de Larochefordiere, A., Graic, Y., de Lafontan, B., … Arriagada, R. (1997). Breast cancer in patients treated for Hodgkin’s disease: clinical and pathological analysis of 76 cases in 63 patients. European Journal of Cancer (Oxford, England: 1990), 33(14), 2315–2320.